Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...
As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities. “To address our current capacity ...
Novo Nordisk has voluntarily recalled insulin cartridge holders used in six NovoPen Echo batches because they may crack or break if exposed to certain chemicals, like certain cleaning agents. Using a ...
On the occasion of the annual congress of the Société francophone du diabète (SFD), in Montpellier, March 21-24, Diabeloop announces a collaboration with Novo Nordisk, a major global healthcare ...
LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of ...
Ahead of World Diabetes Day, Doctors Without Borders/Médecins Sans Frontières (MSF) called for all insulin manufacturers to provide injection pen devices at $1 per pen. The humanitarian organization ...
For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy(R) and Ozempic(R) for only $199 each beginning November 17, 2025 -- Also effective November 17, ...
This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. The connected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback